GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (OTCPK:LPCUF) » Definitions » 5-Year Dividend Growth Rate

LPCUF (Lee's Pharmaceutical Holdings) 5-Year Dividend Growth Rate : -25.60% (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Lee's Pharmaceutical Holdings 5-Year Dividend Growth Rate?

Lee's Pharmaceutical Holdings's Dividends per Share for the six months ended in Dec. 2024 was $0.00.

During the past 12 months, Lee's Pharmaceutical Holdings's average Dividends Per Share Growth Rate was 66.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -21.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -25.60% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -13.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Lee's Pharmaceutical Holdings was 36.20% per year. The lowest was -34.80% per year. And the median was 7.70% per year.

Lee's Pharmaceutical Holdings's Dividend Payout Ratio for the six months ended in Dec. 2024 was 0.43. As of today, Lee's Pharmaceutical Holdings's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Lee's Pharmaceutical Holdings's 5-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lee's Pharmaceutical Holdings's 5-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Lee's Pharmaceutical Holdings's 5-Year Dividend Growth Rate falls into.


;
;

Lee's Pharmaceutical Holdings 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Lee's Pharmaceutical Holdings  (OTCPK:LPCUF) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Lee's Pharmaceutical Holdings's Dividend Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2024 )/ EPS without NRI (Q: Dec. 2024 )
=0.003/ 0.007
=0.43

During the past 13 years, the highest Dividend Payout Ratio of Lee's Pharmaceutical Holdings was 0.86. The lowest was 0.02. And the median was 0.28.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Lee's Pharmaceutical Holdings Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
HKD 0.0200002024-09-122024-09-162024-10-03Cash Dividendsemi-annuallyHKD:USD 0.128712
HKD 0.0100002024-05-282024-05-302024-06-17Cash Dividendsemi-annuallyHKD:USD 0.127879

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Lee's Pharmaceutical Holdings's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.00385303/0.1882
=2.05 %

Current Share Price is $0.1882.
Lee's Pharmaceutical Holdings's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.00385303.

During the past 13 years, the highest Dividend Yield of Lee's Pharmaceutical Holdings was 4.42%. The lowest was 0.00%. And the median was 1.67%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lee's Pharmaceutical Holdings 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Lee's Pharmaceutical Holdings Business Description

Traded in Other Exchanges
Address
Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG
Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.

Lee's Pharmaceutical Holdings Headlines

No Headlines